Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROXITHROMYCIN vs ROZANOLIXIZUMAB-NOLI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROXITHROMYCIN vs ROZANOLIXIZUMAB-NOLI: Safety Overview

Metric ROXITHROMYCIN ROZANOLIXIZUMAB-NOLI
Total FAERS Reports 352 349
Deaths Reported 43 4
Death Rate 12.2% 1.1%
Hospitalizations 189 84
Average Patient Age 57.9 yrs 55.1 yrs
% Female Patients 57.9% 63.3%
Marketing Status N/A Prescription